Rapid Itch Relief in Eczema: New JDD Data on Moisturizer and Cream Performance
This is a must-read article from JDD for dermatologists and dermatology healthcare professionals following the day-to-day management of eczema. Itch remains one of the most challenging symptoms in atopic dermatitis and eczema-prone skin, and this study takes a closer look at how two Cetaphil Restoraderm products performed in a controlled setting.
In this randomized, split-body study, participants with mild to moderate itch and eczema-prone skin applied either an eczema moisturizer or an eczema cream. The investigators assessed how quickly itch relief began, how itch severity changed over time, and how the products were tolerated. For clinicians who counsel patients on skincare as part of eczema management, the findings may be especially relevant.
According to the abstract, both products were associated with rapid onset of itch relief after a single application, along with sustained improvement over 24 hours. Participants also reported strong satisfaction, and the products were described as well tolerated. While moisturizer remains a core part of eczema care, studies like this help add practical data around symptom relief, patient experience, and real world usability.
For practicing dermatologists, this JDD article may be useful when discussing supportive skincare options with patients who struggle with persistent itch and barrier dysfunction. If you manage eczema regularly, take a closer look at the full study to see how these products were evaluated and what the results may mean for your clinical approach.
Blog write-up assisted by AI
